Respiratory Care Domain Perfectly Ripe for Adoption of Digital Devices

DUBLIN, July 7, 2023 /PRNewswire/ — The “Digital Dose Inhalers: Global Strategic Business Report” report has been added to  ResearchAndMarkets.com’s offering. The global market for Digital Dose Inhalers estimated at US$2.9 Billion in the year 2022, is projected to reach a revised size of US$7.2 Billion by 2030, growing at a CAGR of 12.1% over … Read more

CVS Health announces quarterly dividend

WOONSOCKET, R.I., July 7, 2023 /PRNewswire/ — CVS Health (NYSE: CVS) has announced that its board of directors has approved a quarterly dividend of sixty and a half cents ($0.605 cents) per share on the Common Stock of the Corporation. The dividend is payable on August 1, 2023, to holders of record on July 21, … Read more

Rise in Awareness Regarding CAR T-Cell Therapy Drives Growth

DUBLIN, July 6, 2023 /PRNewswire/ — The “CAR-T Cell Therapy Market Share, Size, Trends, Industry Analysis Report, By Target Antigen, By Indication, By Region, Segment Forecast, 2023-2032” report has been added to  ResearchAndMarkets.com’s offering. The global CAR-T cell therapy market size is expected to reach USD 118,680.68 million by 2032, according to a new study. This … Read more

CAR T-Cell Study Enabled by 10x Genomics Single Cell Technology Published in Nature Medicine

Data Uncovers New Gene Signature to Help Understand Persistence in CAR T-cells PLEASANTON, Calif., July 5, 2023 /PRNewswire/ — 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, announced today that its single-cell genomic technologies were used in a study published in the journal Nature Medicine about new gene signatures that explain why some … Read more

Liquid Biopsy Market size is set to grow by USD 1.74 billion from 2021 to 2026|Increasing incidence of cancer is one of the key drivers

NEW YORK, July 4, 2023 /PRNewswire/ — The liquid biopsy market size is estimated to grow by USD 1.74 billion from 2021 to 2026, according to Technavio. The market is estimated to grow at a CAGR of 18.77% during the forecast period. However, the growth momentum will be progressing. North America is estimated to account for 55% … Read more

Asthma Market Insights, Epidemiology and Market Forecasts, 2019-2023 & 2023-2032

DUBLIN, July 4, 2023 /PRNewswire/ — The “Asthma – Market Insight, Epidemiology and Market Forecast – 2032” report has been added to  ResearchAndMarkets.com’s offering. This Asthma- Market Insights, Epidemiology, and Market Forecast-2032 report delivers an in-depth understanding of the Asthma, historical and forecasted epidemiology as well as the Asthma market trends in the United States, EU5 … Read more

China Online Healthcare Market Insights & Forecasts Report 2023-2027 Featuring Leading Players

DUBLIN, July 3, 2023 /PRNewswire/ — The “China Online Healthcare Market: Insights & Forecast with Potential Impact of COVID- 19)” report has been added to  ResearchAndMarkets.com’s offering. China online healthcare market is forecasted to reach US$426.39 billion in 2027, experiencing growth at a CAGR of 36.89% during the period spanning from 2023 to 2027. The competitive … Read more

Fair Play Menarini International Awards, a edição de 2023 começa com o talk show “The Champions tell their Stories” na Piazza della Signoria, em Florença

FLORENÇA, Itália, 2 de julho de 2023 /PRNewswire/ — A contagem regressiva começou para a edição XXVII do Fair Play Menarini International Awards. Amanhã, segunda-feira, dia 3 de julho, a edição 2023 do evento, dedicada aos valores esportivos de ética, fair play e respeito, começará oficialmente na cidade de Florença, com o aguardado talk show “The … Read more

Cyltezo®, first and only FDA-approved Interchangeable biosimilar to Humira®, now commercially available in the U.S.

Cyltezo® (adalimumab-adbm) expands treatment options for patients across multiple chronic inflammatory diseases Cyltezo is the only adalimumab biosimilar with Phase III comparative clinical studies in rheumatoid arthritis, plaque psoriasis and Crohn’s disease RIDGEFIELD, Conn., July 1, 2023 /PRNewswire/ — Boehringer Ingelheim announced today that Cyltezo® (adalimumab-adbm), a U.S. Food and Drug Administration (FDA)-approved Interchangeable biosimilar to Humira® … Read more

AMA issues CPT III code for icometrix’ AI-related brain MRI quantification software

This first CPT III code for AI-supported brain MRI reading brings icometrix to the standard of care BOSTON and LEUVEN, Belgium , July 1, 2023 /PRNewswire/ — The American Medical Association (AMA) has issued a Current Procedural Terminology (CPT) code for icometrix’ FDA-cleared, AI-related brain MRI quantification software, thereby creating a path to reimbursement.  The American … Read more